Cationic solid lipid nanoparticles (cSLN): Structure, stability and DNA binding capacity correlation studies

International Journal of Pharmaceutics

Volumn 420, Issue 2, 2011, Pages 341-349

  Doktorovova, S ^a,b   Shegokar, R ^b   Rakovsky, E ^c   Gonzalez Mira, E ^d   Lopes, C M ^a,e   Silva, A M ^f   Martins Lopes, P ^a   Muller, R H ^b   Souto, E B ^a,e  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c Physics and Informatics   (Slovakia)

^d UNIVERSITY OF BARCELONA   (Spain)

^e UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^f UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Differential scanning calorimetry; Gene delivery; Solid lipid nanoparticles; Stability studies; Wide angle X ray scattering

Indexed keywords

CATIONIC SOLID LIPID NANOPARTICLE; CETRIMIDE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DNA BINDING; DRUG STABILITY; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CATIONS; CETRIMONIUM COMPOUNDS; DNA; DRUG CARRIERS; DRUG STABILITY; GLYCERIDES; NANOPARTICLES; PARTICLE SIZE; POLOXAMER; SURFACE-ACTIVE AGENTS; X-RAY DIFFRACTION;

EID: 80054694297     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.08.042     Document Type: Article

References (27)

1. O.M. Aleekseev, M.M. Lazarenko, G.O. Puchkovska, T.V. Bezrodnaya, and A.A. Sendzyuk Peculiarities if the thermal motion in crystals formed by cetyltrimethylsmmonium bromide molecules Ukr. J. Phys. 55 2010 973 979
2. M. Bhalekar, V. Pokharkar, A. Madgulkar, N. Patil, and N. Patil Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery AAPS PharmSciTech 10 2009 289 296
3. M.L. Bondi, A. Azzolina, E.F. Craparo, N. Lampiasi, G. Capuano, G. Giammona, and M. Cervello Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery J. Drug Target. 15 2007 295 301 (Pubitemid 47161496)
4. M.L. Bondi, and E.F. Craparo Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art Expert Opin. Drug Deliv. 7 2010 7 18
5. J.B. Brubach, V. Jannin, B. Mahler, C. Bourgaux, P. Lessieur, P. Roy, and M. Ollivon Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy Int. J. Pharm. 336 2007 248 256 (Pubitemid 46670648)
6. H. Bunjes Lipid nanoparticles for the delivery of poorly water-soluble drugs J. Pharm. Pharmacol. 62 2010 1637 1645
7. H. Bunjes, and T. Unruh Characterization of lipid nanoparticles by differential scanning calorimetry. X-ray and neutron scattering Adv. Drug Deliv. Rev. 59 2007 379 402 (Pubitemid 47259221)
8. Compritol 888 ATO Technical Data Sheet, Gattefosse 2011 SAS France
9. Z. Cui, and R.J. Mumper Genetic immunization using nanoparticles engineered from microemulsion precursors Pharm. Res. 19 2002 939 946 (Pubitemid 34804235)
10. A. del Pozo-Rodríguez, D. Delgado, M.Á. Solinís, J.L. Pedraz, E. Echevarría, J.M. Rodríguez, and A.R. Gascón Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration Int. J. Pharm. 385 2010 157 162
11. C. Freitas, and R.H. Müller Correlation between long-term stability of solid lipid nanoparticles (SLN(TM)) and crystallinity of the lipid phase Eur. J. Pharm. Biopharm. 47 1999 125 132 (Pubitemid 29185115)
12. J. Hamdani, A.J. Moes, and K. Amighi Physical and thermal characterisation of Precirol™ and Compritol™ as lipophilic glycerides used for preparation of a controlled-release matric pellets Int. J. Pharm. 260 2003 47 57 (Pubitemid 36724860)
13. IMWITOR® Glyceryl Stearates Product Information 2008 Sasol Germany, GmbH
14. R. Ivanova, P. Alexandridis, and B. Lindman Interaction of poloxamer block copolymers with cosolvents and surfactants Colloids Surf., A 183-185 2001 41 53 (Pubitemid 32401097)
15. P.P. Karmali, and A. Chaudhuri Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises ChemInform 5 2007 696 722 (Pubitemid 47282449)
16. N. Krog Crystallization properties and lyotropic phase behavior of food emulsifiers: relation to technical applications 505 N. Garti, Crystalization Processes in Fats and Lipid Systems 2001 Macel Dekker
17. G. Montana, M.L. Bondi, R. Carrotta, P. Picone, E.F. Craparo, P.L. San Biagio, G. Giammona, and M. Di Carlo Employment of cationic solid-lipid nanoparticles as RNA carriers Bioconjug. Chem. 18 2007 302 308 (Pubitemid 46493499)
18. R.H. Müller, S.A. Runge, V. Ravelli, A.F. Thünemann, W. Mehnert, and E.B. Souto Cyclosporine-loaded solid lipid nanoparticles (SLN®): drug-lipid physicochemical interactions and characterization of drug incorporation Eur. J. Pharm. Biopharm. 68 2008 535 544 (Pubitemid 351318197)
19. Z. Rahman, A.S. Zidan, and M.A. Khan Non-destructive methods of characterization of risperidone solid lipid nanoparticles Eur. J. Pharm. Biopharm. 76 2010 127 137
20. M.J. Rosen Emulsification by surfactants M.J. Rosen, Surfactants and Interfacial Phenomena 3rd ed. 2004 John Wiley and Sons Hoboken, New Jersey 303 332
21. R. Shegokar, K.K. Singh, and R.H. Müller Production & stability of stavudine solid lipid nanoparticles - from lab to industrial scale Int. J. Pharm. 416 2011 461 470
22. A. Siddiqui, G.A. Patwardhan, Y.-Y. Liu, and S. Nazzal Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: in vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells Int. J. Pharm. 400 2010 251 259
23. E.B. Souto, S. Doktorovová, and P. Boonme Lipid-based colloidal systems (nanoparticles, microemulsions) for drug delivery to the skin: materials and end-product formulations J. Drug Deliv. Sci. Technol. 21 2011 43 54
24. E.B. Souto, W. Mehnert, and R.H. Müller Polymorphic behaviour of Compritol® 888 ATO as bulk lipid and as SLN and NLC J. Microencapsul. 23 2006 417 433 (Pubitemid 44132550)
25. E.B. Souto, and R.H. Müller Lipid nanoparticles (SLN and NLC) for drug delivery A.J. Domb, Y. Tabata, M.N.V. Ravi Kumar, S. Farber, Nanoparticles for Pharmaceutical Applications 2007 American Scientific Publishers Los Angeles, California 103 122
26. E. Vighi, B. Ruozi, M. Montanari, R. Battini, and E. Leo Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid Eur. J. Pharm. Biopharm. 67 2007 320 328 (Pubitemid 47211893)
27. H.Y. Xue, and H.L. Wong Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization Biomaterials 32 2011 2662 2672